Current role
Biotechnology · Healthcare
Board Member
2024-07-16–present
Mark C. McKenna
Board Member
NewAmsterdam Pharma Co N.V. (NAMS)Equibles does not estimate personal net worth.
About Mark C. McKenna
Mark C. McKenna is recorded as Board Member at NewAmsterdam Pharma Co N.V. (NAMS) since July 16, 2024. NewAmsterdam Pharma Co N.V. reported in an 8-K filed July 18, 2024 that Mark C. McKenna was appointed temporary non-executive director, effective July 16, 2024. NewAmsterdam Pharma Co N.V. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NewAmsterdam Pharma Co N.V. includes Michael Davidson (CEO), Willian H. Lewis, J.D., M.B.A. (Chairman), Ian Somaiya (CFO) and 3 others.
“On July 16, 2024, the Board appointed Wouter Joustra and Mark C. McKenna to serve as members of the Board.”
Affiliation history
-
Current
2024-07-16–present
Company network
Leadership on record at NewAmsterdam Pharma Co N.V.
- Michael Davidson CEO
- Willian H. Lewis, J.D., M.B.A. Chairman
- Ian Somaiya CFO
- Robert W. Gunning Chief Accounting Officer
- Adele Gulfo Board Member
- Wouter Joustra Board Member